1 daily https://www.pchc.eu/en/ 0.9 daily https://www.pchc.eu/en/who-we-are 0.9 daily https://www.pchc.eu/en/research-themes 0.9 daily https://www.pchc.eu/en/resources 0.9 daily https://www.pchc.eu/en/publications 0.9 daily https://www.pchc.eu/en/news-and-events 0.9 daily https://www.pchc.eu/en/privacy-policy 0.9 daily https://www.pchc.eu/en/impressum 0.8 daily https://www.pchc.eu/en/news-and-events/news 0.8 daily https://www.pchc.eu/en/ressourcen/educational-material 0.8 daily https://www.pchc.eu/en/news-and-events/events 0.8 daily https://www.pchc.eu/en/ressourcen/clinical-and-patient-reported-outcome-measures-pros 0.7 daily https://www.pchc.eu/en/who-we-are/dr-caroline-f-z-stuhlmann 0.7 daily https://www.pchc.eu/en/who-we-are/khadija-rudloff 0.7 daily https://www.pchc.eu/en/who-we-are/marielle-donié-m-sc 0.7 daily https://www.pchc.eu/en/who-we-are/juliane-traxler-m-sc 0.7 daily https://www.pchc.eu/en/who-we-are/sophie-kiesewetter 0.7 daily https://www.pchc.eu/en/who-we-are/dr-neuza-da-silva-burger 0.7 daily https://www.pchc.eu/en/who-we-are/dr-catharina-braren-von-stülpnagel-m-sc 0.7 daily https://www.pchc.eu/en/who-we-are/pd-dr-rachel-sommer 0.7 daily https://www.pchc.eu/en/who-we-are/lukas-westphal-m-sc 0.7 daily https://www.pchc.eu/en/who-we-are/prof-dr-matthias-augustin 0.7 daily https://www.pchc.eu/en/research-themes/patient-reported-and-clinical-outcomes 0.7 daily https://www.pchc.eu/en/research-themes/assessment-of-illness-burden-and-patient-needs 0.7 daily https://www.pchc.eu/en/research-themes/treatment-effects 0.7 daily https://www.pchc.eu/en/research-themes/interventions 0.7 daily https://www.pchc.eu/en/research-themes/stigmatization 0.7 daily https://www.pchc.eu/en/research-themes/cumulative-life-course-impairment 0.7 daily https://www.pchc.eu/en/publications/well-being-in-german-patients-with-vitiligo-in-genital-and-visible-areas-a-pilot-study 0.7 daily https://www.pchc.eu/en/publications/validation-of-the-german-version-of-infants-and-toddlers-dermatology-quality-of-life-intodermqol-questionnaire 0.7 daily https://www.pchc.eu/en/publications/prevalence-of-genital-psoriasis-and-its-impact-on-patients-sexual-life-in-routine-care-epidemiologic-survey-in-germany 0.7 daily https://www.pchc.eu/en/publications/testing-undergraduate-medical-students-ability-to-correctly-identify-skin-conditions-in-skin-of-color-a-pre-post-study-at-a-medical-school-in-germany 0.7 daily https://www.pchc.eu/en/publications/efficacy-of-an-intervention-to-reduce-stigma-towards-people-with-skin-diseases-among-health-and-body-care-professionals-a-randomized-controlled-trial 0.7 daily https://www.pchc.eu/en/publications/family-dermatology-life-quality-index-f-dlqi-german-validation-and-applicability-to-parents-of-infants-and-toddlers-with-dermatological-conditions 0.7 daily https://www.pchc.eu/en/publications/assessing-quality-of-life-in-infants-and-toddlers-with-dermatological-conditions-validation-of-the-intodermqol-questionnaire-german-version 0.7 daily https://www.pchc.eu/en/publications/vitiligo-im-dialog-die-plenumsdiskussion 0.7 daily https://www.pchc.eu/en/publications/communication-and-treatment-planning-in-reproductive-age-psoriasis-patients-undergoing-immunomodulatory-therapy-a-survey-in-the-german-psoriasis-registry-psobest 0.7 daily https://www.pchc.eu/en/publications/identification-of-stigmatization-and-relevant-predictors-in-people-with-alopecia-areata-and-androgenetic-alopecia-a-comparative-cross-sectional-study-in-german-speaking-countries-and-the-usa 0.7 daily https://www.pchc.eu/en/publications/skin-love-entwicklung-und-anwendung-einer-methodik-zur-charakterisierung-des-emotionalen-verhältnisses-mit-der-haut 0.7 daily https://www.pchc.eu/en/publications/communication-and-therapy-planning-for-patients-of-reproductive-age-under-immunomodulatory-treatments-for-psoriasis-or-psoriatic-arthritis-survey-of-the-german-national-psoriasis-registry-psobest 0.7 daily https://www.pchc.eu/en/publications/patient-reported-impact-of-dermatological-diseases-and-mental-health6 0.7 daily https://www.pchc.eu/en/publications/erfassung-der-lebensqualität-bei-säuglingen-und-kleinkindern-mit-hauterkrankungen-validierung-des-deutschen-intodermqol-fragebogens 0.7 daily https://www.pchc.eu/en/publications/the-global-research-on-the-impact-of-dermatological-diseases-gridd-in-germany 0.7 daily https://www.pchc.eu/en/publications/patient-reported-impact-of-dermatological-diseases-and-mental-health 0.7 daily https://www.pchc.eu/en/publications/implementation-of-a-team-teaching-seminar-on-the-stigmatization-and-psychosocial-burdens-of-people-with-visible-skin-diseases-in-the-standard-curriculum-of-medical-studies 0.7 daily https://www.pchc.eu/en/publications/psychosoziale-gesundheit-und-vitiligo-in-deutschland-was-wollen-wir-wissen-und-wozu 0.7 daily https://www.pchc.eu/en/publications/reduktion-von-stigmatisierenden-einstellungen-bei-angehörigen-körpernaher-berufe-gegenüber-menschen-mit-hauterkrankungen-ergebnisse-einer-randomisiert-kontrollierten-studie 0.7 daily https://www.pchc.eu/en/publications/analyse-des-neuen-derm-clci-r-fragebogens-zur-erfassung-kumulierender-krankheitsbelastungen-bei-patienten-mit-atopischer-dermatitis 0.7 daily https://www.pchc.eu/en/publications/digitale-versorgungskonzepte-und-die-rolle-der-therapeutischen-allianz-in-der-psychodermatologie 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-a-self-compassion-programme-to-reduce-self-stigma-in-chronic-skin-diseases-the-hautkompass-rct8 0.7 daily https://www.pchc.eu/en/publications/interdisciplinary-care-in-immune-mediated-inflammatory-diseases-with-skin-manifestations-within-the-who-s-people-centred-healthcare-framework 0.7 daily https://www.pchc.eu/en/publications/responsiveness-and-minimally-important-change-of-the-patient-reported-impact-of-dermatological-diseases-pridd-questionnaire 0.7 daily https://www.pchc.eu/en/publications/version-of-the-family-dermatology-life-quality-index-f-dlqi6 0.7 daily https://www.pchc.eu/en/publications/version-of-the-family-dermatology-life-quality-index-f-dlqi 0.7 daily https://www.pchc.eu/en/publications/benefits-and-satisfaction-with-apremilast-treatment-in-patients-with-psoriasis-affecting-the-genital-area-secondary-analysis-of-the-appreciate-study 0.7 daily https://www.pchc.eu/en/publications/psychosomatic-dermatology-link-between-positive-affect-and-healthy-skin 0.7 daily https://www.pchc.eu/en/publications/erfassung-der-lebensqualität-bei-säuglingen-und-kleinkindern-mit-hauterkrankungen-validierung-des-deutschen-intodermqol-fragebogens4 0.7 daily https://www.pchc.eu/en/publications/iwell-being-in-german-patients-with-vitiligo-in-genital-and-visible-areas-a-pilot-study 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-a-self-compassion-programme-to-reduce-self-stigma-in-chronic-skin-diseases-the-hautkompass-rct 0.7 daily https://www.pchc.eu/en/publications/cumulative-life-course-impairment-clci-messung-der-kumulierenden-lebensbelastungen-bei-patienten-mit-psoriasis-in-der-routineversorgung-mit-einem-validierten-instrument 0.7 daily https://www.pchc.eu/en/publications/workshop-stigmatisierung-bei-hautpatient-innen 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-the-hautkompass-online-programme-in-reducing-self-stigma-in-people-with-chronic-skin-diseases-a-randomized-controlled-trial 0.7 daily https://www.pchc.eu/en/publications/patient-reported-well-being-in-value-based-routine-care-using-tildrakizumab-52-week-interim-data-of-the-phase-iv-positive-study5 0.7 daily https://www.pchc.eu/en/publications/wirksamkeit-des-online-programms-hautkompass 0.7 daily https://www.pchc.eu/en/publications/reducing-self-stigma-and-fostering-acceptance-in-people-living-with-chronic-skin-disease-through-an-online-program-results-of-the-hautkompass-rct 0.7 daily https://www.pchc.eu/en/publications/interventions-to-reduce-skin-related-self-stigma-a-systematic-review 0.7 daily https://www.pchc.eu/en/publications/growth-hormone-treatment-in-children-with-short-stature-impact-of-the-diagnosis-on-parents8 0.7 daily https://www.pchc.eu/en/publications/predictors-and-mechanisms-of-self-stigma-in-five-chronic-skin-diseases-a-systematic-review 0.7 daily https://www.pchc.eu/en/publications/patient-reported-well-being-using-tildrakizumab-in-a-real-world-setting-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/disease-burden-patient-needs-and-family-planning-in-women-of-childbearing-age-with-moderate-to-severe-psoriasis-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/development-and-evaluation-of-the-hautkompass-online-program-targeting-self-stigma-in-chronic-skin-disease-am103 0.7 daily https://www.pchc.eu/en/publications/reducing-self-stigma-in-chronic-skin-disease-development-and-pilot-test-of-the-hautkompass-online-programme-presentation-ehps 0.7 daily https://www.pchc.eu/en/publications/socio-demographic-diversity-of-the-impact-of-dermatological-diseases-results-from-the-patient-initiated-global-research-on-the-impact-of-dermatological-disease-gridd-study 0.7 daily https://www.pchc.eu/en/publications/vitiligo-a-disease-a-position-paper-on-stigmatization-life-quality-impairment-and-psychosocial-comorbidity 0.7 daily https://www.pchc.eu/en/publications/impact-of-patient-psoriasis-on-partner-well-being-in-a-real-world-setting-52-week-interim-data-of-the-phase-iv-positive-study-eadv-congress-2024-amsterdam16 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-tildrakizumab-in-patients-with-moderate-to-severe-psoriasis-located-in-special-areas-52-week-results-from-the-positive-study-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/growth-hormone-treatment-in-children-with-short-stature-impact-of-the-diagnosis-on-parents2 0.7 daily https://www.pchc.eu/en/publications/assessing-quality-of-life-in-children-with-dermatological-conditions-validation-of-the-intodermqol-questionnaire-presentation-dkvf20248 0.7 daily https://www.pchc.eu/en/publications/patients-with-psoriasis-perceive-major-life-changing-events-in-physical-psychological-and-care-dimensions-results-from-the-dermclci-r-questionnaire-in-routine-care-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/patient-needs-in-women-of-childbearing-age-with-psoriasis-retrospective-analysis-from-the-german-psobest-registry 0.7 daily https://www.pchc.eu/en/publications/need-for-individualized-counseling-regarding-psoriasis-systemic-therapy-in-women-of-childbearing-age 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-tildrakizumab-for-itch-pain-and-fatigue-in-patients-with-moderate-to-severe-psoriasis-52-week-results-from-the-real-world-positive-study-eadv-congress-2024-amsterdam0 0.7 daily https://www.pchc.eu/en/publications/assessing-quality-of-life-in-children-with-dermatological-conditions-validation-of-the-intodermqol-questionnaire-presentation-dkvf2024 0.7 daily https://www.pchc.eu/en/publications/breaking-barriers-randomized-controlled-trials-assessing-an-intervention-to-combat-stigma-in-chronic-skin-disease-presentation-am10 0.7 daily https://www.pchc.eu/en/publications/tackling-self-stigma-in-chronic-skin-disease-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis2 0.7 daily https://www.pchc.eu/en/publications/high-effectiveness-of-tildrakizumab-in-bio-naïve-and-bio-experienced-patients-with-moderate-to-severe-psoriasis-52-week-results-from-the-positive-study-eadv-congress-2024-amsterdam1 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-work-productivity-and-treatment-satisfaction-with-tildrakizumab-in-moderate-to-severe-psoriasis-patients-52-week-interim-data-of-the-real-world-positive-study-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/the-burden-of-dermatological-diseases-is-global-but-unequal-across-the-globe-comparative-analyses-of-patient-reported-impact-of-dermatological-diseases-pridd-across-socio-demographic-groups-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/high-effectiveness-of-tildrakizumab-regardless-of-baseline-characteristics-in-patients-with-moderate-to-severe-psoriasis-52-week-results-from-the-positive-study-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis46076 0.7 daily https://www.pchc.eu/en/publications/safety-of-tildrakizumab-in-patients-with-moderate-to-severe-psoriasis-52-week-data-from-the-phase-iv-positive-study-eadv-congress-2024-amsterdam 0.7 daily https://www.pchc.eu/en/publications/entwicklung-und-evaluation-einer-online-intervention-zur-reduktion-von-selbststigmatisierung-bei-menschen-mit-sichtbaren-chronischen-hauterkrankungen-presentation-dkvf20246 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8395 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8396 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review54 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis4 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis46 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis22 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis9 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis4 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis460769 0.7 daily https://www.pchc.eu/en/publications/patient-reported-well-being-using-tildrakizumab-in-a-real-world-setting-28-week-interim-data-of-the-phase-iv-positive-study 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis460765 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis460 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review92 0.7 daily https://www.pchc.eu/en/publications/development-of-an-online-intervention-to-prevent-self-stigmatization-in-people-with-visible-chronic-skin-diseases 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-defined-treatment-needs-and-benefits-in-patients-with-psoriasis-with-and-without-anogenital-involvement 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis25 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5477 0.7 daily https://www.pchc.eu/en/publications/implementing-wellbeing-in-the-management-of-psoriasis-an-expert-recommendation 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-a-structured-short-intervention-against-stigmatizing-attitudes-towards-people-with-skin-diseases-in-body-care-professions 0.7 daily https://www.pchc.eu/en/publications/associations-between-disease-burden-and-mental-health-outcomes-in-male-and-female-patients-with-anogenital-psoriasis-the-mediating-role-of-social-avoidance-and-cognitive-distraction-coping 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review4 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review85 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review58 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis3 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5474 0.7 daily https://www.pchc.eu/en/publications/everybody-copes-an-interprofessional-workshop-on-stress-coping-and-helping-primary-care-patients-manage-medical-stressors 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review830 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review839 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review83 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5478 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review548 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5477 0.7 daily https://www.pchc.eu/en/publications/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis25 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review830 0.7 daily https://www.pchc.eu/en/publications/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review85 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-of-children-and-adolescents-with-short-stature-the-twofold-contribution-of-physical-growth-and-adaptive-height-related-cognitive-beliefs 0.7 daily https://www.pchc.eu/en/publications/patient-physician-dis-agreement-on-their-reports-of-body-surface-area-affected-by-psoriasis-and-ist-associations-with-disease-burden 0.7 daily https://www.pchc.eu/en/publications/psychological-co-morbidity-in-patients-with-psoriasis-the-impact-of-pruritus-and-anogenital-involvement-on-symptoms-of-depression-and-anxiety-and-on-body-dysmorphic-concerns-a-cross-sectional-study 0.7 daily https://www.pchc.eu/en/publications/measuring-patient-relevant-benefits-in-the-treatment-of-psoriasis-with-the-patient-benefit-index-development-and-preliminary-validation-of-a-10-item-short-form 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-intodermqol 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire 0.7 daily https://www.pchc.eu/en/publications/acad-dermatol-venereol-2021-sommer-development-and-validation-of-an-outcome-instrument-measuring-dry-skin-the-xerosis-area-and-severity-index-xasi5 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis2 0.7 daily https://www.pchc.eu/en/publications/parents-with-asthmatic-children-quality-of-life 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol4 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire1 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire73 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire144 0.7 daily https://www.pchc.eu/en/publications/dermatological-care-of-elderly-people-with-psoriasis-before-and-after-entering-a-nursing-home-a-qualitative-analysis-from-the-perspective-of-medical-providers 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol2 0.7 daily https://www.pchc.eu/en/publications/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire14 0.7 daily https://www.pchc.eu/en/publications/4how-do-dermatologists-personal-models-inform-a-patient-centred-approach-to-management-a-qualitative-study-using-the-example-of-prescribing-a-new-treatment-apremilast 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol8 0.7 daily https://www.pchc.eu/en/publications/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire7 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol471 0.7 daily https://www.pchc.eu/en/publications/measuring-well-being-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol47 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol83 0.7 daily https://www.pchc.eu/en/publications/psychometric-properties-of-the-short-version-of-the-freiburg-life-quality-assessment-for-chronic-venous-disease 0.7 daily https://www.pchc.eu/en/publications/developments-in-quality-of-life-assessment-in-children-with-dermatological-conditions-validation-protocol-for-the-german-version-of-the-into-dermqol43 0.7 daily https://www.pchc.eu/en/publications/development-and-validation-of-an-outcome-instrument-measuring-dry-skin-the-xerosis-area-and-severity-index-xasi 0.7 daily https://www.pchc.eu/en/publications/exploring-the-burden-of-xerosis-cutis-and-the-impact-of-dermatological-skin-care-from-patient-s-perspective 0.7 daily https://www.pchc.eu/en/publications/skin-lesions-skin-care-and-characteristics-of-pruritus-in-patients-undergoing-haemodialysis 0.7 daily https://www.pchc.eu/en/publications/klinische-studien-teil-1-daten-und-ergebnisse-besser-verstehen 0.7 daily https://www.pchc.eu/en/publications/stigma-in-visible-skin-diseases-a-literature-review-and-development-of-a-conceptual-model 0.7 daily https://www.pchc.eu/en/publications/topologie-der-psoriasis-eine-prävalenzanalyse-aus-real-world-daten-im-längs-und-querschnitt 0.7 daily https://www.pchc.eu/en/publications/assessing-the-quality-of-life-of-people-with-chronic-wounds-by-using-the-cross-culturally-valid-and-revised-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/en/publications/klinische-studien-teil-1-daten-und-ergebnisse-besser-verstehen8 0.7 daily https://www.pchc.eu/en/publications/patient-reported-outcomes-measures-measuring-wellbeing-not-only-burden-of-disease 0.7 daily https://www.pchc.eu/en/publications/disease-severity-and-patient-needs-benefits-in-genital-psoriasis-patient-reported-improvement-after-6-1-months-of-apremilast-treatment 0.7 daily https://www.pchc.eu/en/publications/was-wünschen-sich-patienten-mit-sichtbaren-hauterkrankungen-und-welche-probleme-beschäftigen-sie-im-alltag 0.7 daily https://www.pchc.eu/en/publications/interpersonal-experiences-of-stigmatization-and-sexual-impairments-quality-of-life-and-depression-in-patients-with-psoriasis-the-mediating-role-of-social-avoidance-coping 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-needs-benefits-in-patients-with-psoriasis-with-and-without-anogenital-involvement-preliminary-results-from-the-psogen-study 0.7 daily https://www.pchc.eu/en/publications/psychosocial-function-of-vitiligo-patients-in-the-face-of-stigmatization-a-systematic-review 0.7 daily https://www.pchc.eu/en/publications/secukinumab-effects-on-patient-reported-outcomes-in-plaque-psoriasis-across-europe-data-from-the-prose-study 0.7 daily https://www.pchc.eu/en/publications/effects-of-secukinumab-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-s-perspective-data-from-the-prose-study 0.7 daily https://www.pchc.eu/en/publications/the-importance-of-patient-centered-healthcare-against-comorbid-depression-and-anxiety-in-patients-with-psoriasis 0.7 daily https://www.pchc.eu/en/publications/patients-and-physicians-perspectives-on-body-surface-area-affected-by-psoriasis-links-between-disease-burden-patient-physician-dis-agreement-and-patient-benefits 0.7 daily https://www.pchc.eu/en/publications/cumulative-life-course-impairment-systematisches-review-zur-bestimmung-von-indikatoren 0.7 daily https://www.pchc.eu/en/publications/xerosis-cutis-und-stigmatisierung-patientensicht-bei-hauterkrankungen-und-erkenntnisse-über-die-auswirkungen-einer-hautpflege 0.7 daily https://www.pchc.eu/en/publications/effectiveness-of-a-structured-short-intervention-against-stigmatisation-in-chronic-visible-skin-diseases-results-of-a-controlled-trial-in-future-educators 0.7 daily https://www.pchc.eu/en/publications/bestimmung-der-transnationalen-gesundheitsbezogenen-lebensqualität-die-kulturübergreifende-validität-des-überarbeiteten-wound-qol-fragebogens 0.7 daily https://www.pchc.eu/en/publications/significance-of-chronic-pruritus-for-intrapersonal-burden-and-interpersonal-experiences-of-stigmatization-and-sexuality-in-patients-with-psoriasis 0.7 daily https://www.pchc.eu/en/publications/assessment-of-stigma-related-to-visible-skin-diseases-a-systematic-review-and-evaluation-of-patient-reported-outcome-measures 0.7 daily https://www.pchc.eu/en/publications/secukinumab-effects-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-perspective-data-from-the-prose-study 0.7 daily https://www.pchc.eu/en/publications/mapping-risk-factors-for-cumulative-life-course-impairment-in-patients-with-chronic-skin-diseases-a-systematic-review 0.7 daily https://www.pchc.eu/en/publications/determining-the-minimal-important-difference-for-the-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/en/publications/validation-of-the-spanish-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-needs-and-benefits-in-anogenital-psoriasis-developmental-specificities-for-person-centred-healthcare-of-emerging-adults-and-adults 0.7 daily https://www.pchc.eu/en/publications/development-and-psychometric-evaluation-of-the-u-s-english-wound-qol-questionnaire-to-assess-health-related-quality-of-life-in-people-with-chronic-wounds 0.7 daily https://www.pchc.eu/en/publications/the-applicability-of-the-revised-burden-measure-in-pediatric-settings-measuring-parents-caregiving-burdens-and-uplifts 0.7 daily https://www.pchc.eu/en/publications/portuguese-version-of-the-disabkids-diabetes-module 0.7 daily https://www.pchc.eu/en/publications/a-systematic-review-on-quality-of-life-assessment-in-adults-with-cerebral-palsy-challenging-issues-and-a-call-for-research 0.7 daily https://www.pchc.eu/en/publications/nice-kids-healthy-kids-prosocial-behavior-psychological-problems-and-quality-of-life-in-children-preadolescents-and-adolescents-with-and-without-chronic-health-conditions 0.7 daily https://www.pchc.eu/en/publications/body-height-or-height-related-cognitive-beliefs-what-matters-the-most-for-the-health-related-quality-of-life-of-children-and-adolescents-with-short-stature 0.7 daily https://www.pchc.eu/en/publications/disease-severity-and-patient-needs-benefits-in-genital-psoriasis-patient-reported-improvement-after-6-1-months-of-apremilast-treatment-2 0.7 daily https://www.pchc.eu/en/publications/effects-of-secukinumab-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-s-perspective-data-from-the-prose-study-2 0.7 daily https://www.pchc.eu/en/publications/psychological-co-morbidity-in-patients-with-and-without-anogenital-psoriasis-and-chronic-pruritus-associations-between-disease-treatment-burden-and-clinically-significant-symptoms-of-depression-and-anxiety 0.7 daily https://www.pchc.eu/en/publications/patient-physician-dis-agreement-on-their-reports-of-body-surface-area-affected-by-psoriasis-associations-with-disease-burden-and-patient-defined-treatment-benefits 0.7 daily https://www.pchc.eu/en/publications/xerosis-cutis-and-stigmatization-exploring-patient-s-view-of-skin-affections-and-impact-of-skin-care 0.7 daily https://www.pchc.eu/en/publications/development-and-psychometric-evaluation-of-the-u-s-english-wound-qol-questionnaire-to-assess-health-related-quality-of-life-in-people-with-chronic-wounds-2 0.7 daily https://www.pchc.eu/en/publications/psychological-comorbidity-in-patients-with-psoriasis-the-impact-of-pruritus-and-anogenital-involvement-on-symptoms-of-depression-and-anxiety 0.7 daily https://www.pchc.eu/en/publications/cumulative-life-course-impairment-systematisches-review-zur-bestimmung-von-indikatoren-2 0.7 daily https://www.pchc.eu/en/publications/xerosis-cutis-und-stigmatisierung-patientensicht-bei-hauterkrankungen-und-erkenntnisse-über-die-auswirkungen-einer-hautpflege-2 0.7 daily https://www.pchc.eu/en/publications/impact-of-pruritus-in-patients-with-psoriasis-associations-between-disease-burden-patient-needs-and-interpersonal-experiences 0.7 daily https://www.pchc.eu/en/publications/perception-and-determinants-of-stigmatization-of-people-with-psoriasis-in-the-german-population 0.7 daily https://www.pchc.eu/en/publications/gesundheitsökonomie-und-personenzentrierte-versorgung-chronischer-wunden-in-deutschland 0.7 daily https://www.pchc.eu/en/publications/characterizing-treatment-related-patient-needs-in-atopic-eczema-insights-for-personalized-goal-orientation 0.7 daily https://www.pchc.eu/en/publications/instrumentenentwicklung-und-bewertung-bestimmung-der-transnationalen-gesundheitsbezogenen-lebensqualität-die-kulturübergreifende-validität-des-überarbeiteten-wound-qol-fragebogens 0.7 daily https://www.pchc.eu/en/publications/umsetzung-der-wha-resolution-in-deutschland-entwicklung-erprobung-und-evaluation-von-interventionen-zur-entstigmatisierung-von-menschen-mit-sichtbaren-chronischen-hauterkrankungen 0.7 daily https://www.pchc.eu/en/publications/sex-related-impairment-and-patient-needs-benefits-in-anogenital-psoriasis-difficult-to-communicate-topics-and-their-impact-on-patient-centred-care 0.7 daily https://www.pchc.eu/en/publications/impact-of-moderate-to-severe-pruritus-in-patients-with-psoriasis-association-between-disease-burden-patient-needs-and-interpersonal-experiences 0.7 daily https://www.pchc.eu/en/publications/translating-the-wha-resolution-in-a-member-state-development-testing-and-evaluation-of-interventions-against-stigmatization-of-people-with-visible-skin-diseases 0.7 daily https://www.pchc.eu/en/publications/stigmatisierung-durch-haarausfall-eine-systematische-literaturübersicht 0.7 daily https://www.pchc.eu/en/publications/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/en/publications/xerosis-cutis-weit-mehr-als-nur-trockene-haut 0.7 daily https://www.pchc.eu/en/publications/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire-2 0.7 daily https://www.pchc.eu/en/publications/stigmatization-caused-by-hair-loss-a-systematic-literature-review 0.7 daily https://www.pchc.eu/en/publications/significance-and-extent-of-stigmatization-against-persons-with-visible-skin-conditions-in-the-public 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-needs-in-emerging-adults-and-adults-with-psoriasis-addressing-developmental-specificities-for-person-centered-healthcare 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-profile-in-children-adolescents-with-chronic-conditions-a-meta-analysis-with-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/en/publications/psychometric-properties-of-the-quality-of-life-in-short-statured-youth-qolissy-questionnaire-within-the-course-of-growth-hormone-treatment 0.7 daily https://www.pchc.eu/en/publications/skin-disease-implications-for-self-image-development-in-adolescence-and-young-adulthood 0.7 daily https://www.pchc.eu/en/publications/erste-daten-und-strategien-zur-entstigmatisierung 0.7 daily https://www.pchc.eu/en/publications/people-centered-health-care-von-clci-bis-entstigmatisierung-neue-versorgungskonzepte-bei-hauterkrankungen 0.7 daily https://www.pchc.eu/en/publications/leitliniengerechte-behandlung-adhärenz-präferenz 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-of-short-statured-children-born-small-for-gestational-age-or-idiopathic-growth-hormone-deficiency-within-1-year-of-growth-hormone-treatment 0.7 daily https://www.pchc.eu/en/publications/validation-of-the-greek-version-of-quality-of-life-in-short-stature-youth-qolissy-questionnaire 0.7 daily https://www.pchc.eu/en/publications/first-year-predictors-of-health-related-quality-of-life-changes-in-short-statured-children-treated-with-human-growth-hormone 0.7 daily https://www.pchc.eu/en/publications/topology-of-psoriasis-in-routine-care-results-from-high-resolution-analysis-of-2009-patients 0.7 daily https://www.pchc.eu/en/publications/first-year-predictors-of-health-related-quality-of-life-changes-in-short-statured-children-treated-with-human-growth-hormone 0.7 daily https://www.pchc.eu/en/publications/do-8-to-18-year-old-children-adolescents-with-chronic-physical-health-conditions-have-worse-health-related-quality-of-life-than-their-healthy-peers-a-meta-analysis-of-studies-using-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/en/publications/ökonomie-der-wundversorgung-in-dissemond 0.7 daily https://www.pchc.eu/en/publications/sex-related-impairments-and-patient-needs-in-ano-genital-psoriasis-difficult-to-communicate-topics-and-their-impact-on-patient-centred-care 0.7 daily https://www.pchc.eu/en/publications/identifying-specific-patient-needs-and-treatment-goals-in-chronic-spontaneous-urticaria-for-a-patient-centered-clinical-decision-making-process 0.7 daily https://www.pchc.eu/en/publications/significance-and-extent-of-stigmatization-against-persons-with-visible-skin-conditions-in-the-public 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-needs-in-emerging-adults-and-adults-with-psoriasis-addressing-developmental-specificities-for-person-centered-healthcare 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-profile-in-children-adolescents-with-chronic-conditions-a-meta-analysis-with-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/en/publications/skin-disease-implications-for-self-image-development-in-adolescence-and-young-adulthood 0.7 daily https://www.pchc.eu/en/publications/erste-daten-und-strategien-zur-entstigmatisierung 0.7 daily https://www.pchc.eu/en/publications/people-centered-health-care-von-clci-bis-entstigmatisierung-neue-versorgungskonzepte-bei-hauterkrankungen 0.7 daily https://www.pchc.eu/en/publications/leitliniengerechte-behandlung-adhärenz-präferenz 0.7 daily https://www.pchc.eu/en/publications/keeping-a-pro-instrument-alive-the-international-pediatric-disabkids-initiative 0.7 daily https://www.pchc.eu/en/publications/sex-related-impairments-and-patient-needs-in-anogenital-psoriasis-difficult-to-communicate-topics-and-their-impact-on-patient-centred-care 0.7 daily https://www.pchc.eu/en/publications/topology-of-psoriasis-in-sexually-sensitive-and-visible-body-areas-disease-burden-and-patient-needs-in-routine-care 0.7 daily https://www.pchc.eu/en/publications/people-centered-health-care-pchc-a-new-concept-for-characterizing-comprehensive-effective-care-in-dermatology 0.7 daily https://www.pchc.eu/en/publications/patient-needs-and-treatment-goals-in-atopic-eczema-insights-for-patient-centered-routine-care 0.7 daily https://www.pchc.eu/en/publications/cumulative-life-course-impairment-clci-a-concept-supporting-people-centered-care-in-dermatology 0.7 daily https://www.pchc.eu/en/publications/perception-and-predictors-of-prejudice-in-people-with-psoriasis-in-the-german-population 0.7 daily https://www.pchc.eu/en/publications/characterizing-treatment-related-patient-needs-in-atopic-dermatitis-insights-for-personalized-goal-orientation 0.7 daily https://www.pchc.eu/en/publications/disease-burden-related-to-sensitive-body-areas-in-patients-with-psoriasis-results-from-large-scale-studies-in-routine-care 0.7 daily https://www.pchc.eu/en/publications/characteristics-and-determinants-of-patient-burden-and-needs-in-the-treatment-of-chronic-spontaneous-urticarial 0.7 daily https://www.pchc.eu/en/publications/perception-of-stigmatization-of-people-with-psoriasis-a-qualitative-analyses-from-patients-perspective-their-relatives-and-health-care-providers 0.7 daily https://www.pchc.eu/en/publications/characterising-treatment-related-patient-needs-in-atopic-eczema-insights-for-personalised-goal-orientation 0.7 daily https://www.pchc.eu/en/publications/disease-burden-and-patient-needs-related-to-sensitive-body-areas-in-patients-with-psoriasis-results-from-routine-care 0.7 daily https://www.pchc.eu/en/publications/cumulative-life-course-impairment-clci-ein-konstrukt-zur-unterstützung-der-personenzentrierten-gesundheitsversorgung-bei-chronischen-hautkrankheiten 0.7 daily https://www.pchc.eu/en/publications/wahrnehmung-und-prädiktoren-von-vorurteilen-bei-menschen-mit-psoriasis 0.7 daily https://www.pchc.eu/en/publications/charakterisierung-der-behandlungsbezogenen-patientenbedürfnisse-bei-neurodermitis-einblicke-in-eine-personenzentrierte-zielorientierung 0.7 daily https://www.pchc.eu/en/publications/krankheitsbelastung-und-patientenbedarfe-in-bezug-auf-sensible-körperregionen-bei-patienten-mit-psoriasis-ergebnisse-aus-der-routineversorgung 0.7 daily https://www.pchc.eu/en/publications/hautläsionen-hautpflege-und-eigenschaften-von-juckreiz-bei-patienten-mit-urämie-nach-hämodialyse 0.7 daily https://www.pchc.eu/en/publications/merkmale-und-determinanten-von-patientenbedarfen-bei-der-behandlung-von-chronisch-spontaner-urtikaria 0.7 daily https://www.pchc.eu/en/publications/wahrnehmung-der-stigmatisierung-von-menschen-mit-psoriasis-eine-qualitative-analyse-aus-patientensicht-deren-angehörigen-und-leistungserbringern 0.7 daily https://www.pchc.eu/en/publications/entwicklung-und-umsetzung-des-bmg-förderprojektes-zur-entstigmatisierung-bei-menschen-mit-sichtbaren-chronischen-hautkrankheiten-auf-basis-des-who-berichts-zu-psoriasis 0.7 daily https://www.pchc.eu/en/publications/people-centered-health-care-pchc-in-der-dermatologie-ansätze-für-eine-versorgung-im-rahmen-der-who-forderung 0.7 daily https://www.pchc.eu/en/publications/maßnahmen-zum-abbau-von-stigmatisierung-und-ausgrenzung-von-menschen-mit-chronischen-hauterkrankungen-ergebnisse-einer-pilot-intervention-bei-jugendlichen 0.7 daily https://www.pchc.eu/en/publications/same-language-different-culture-differential-item-functioning-and-factor-structure-of-the-disabkids-37-questionnaire-in-portuguese-and-brazilian-children-adolescents-with-asthma-and-diabetes 0.7 daily https://www.pchc.eu/en/publications/differences-between-patient-and-proxy-reported-hrqol-using-the-wound-qol 0.7 daily https://www.pchc.eu/en/publications/versorgungsforschung-in-der-dermatologie-2018-kraft-des-faktischen-was-versorgungsforschung-ist-und-wem-sie-dient 0.7 daily https://www.pchc.eu/en/publications/differences-between-patient-and-proxy-reported-hrqol-using-the-wound-qol-2 0.7 daily https://www.pchc.eu/en/publications/schuppenflechte-oder-psoriasis-wortwahl-und-bekanntheit-der-fachbegriffe-in-der-öffentlichkeit 0.7 daily https://www.pchc.eu/en/publications/what-is-psoriasis-perception-and-assessment-of-psoriasis-among-the-german-population 0.7 daily https://www.pchc.eu/en/publications/was-ist-schuppenflechte-wahrnehmung-und-bewertung-der-psoriasis-in-der-deutschen-bevölkerung 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-in-adolescent-boys-with-idiopathic-short-stature-positive-impact-of-growth-hormone-and-aromatase-inhibitors 0.7 daily https://www.pchc.eu/en/publications/children-s-psychosocial-functioning-and-parents-quality-of-life-in-paediatric-short-stature-the-mediating-role-of-caregiving-stress 0.7 daily https://www.pchc.eu/en/publications/the-psychometric-evaluation-of-the-quality-of-life-in-short-stature-youth-qolissy-instrument-for-german-children-born-small-for-gestational-age 0.7 daily https://www.pchc.eu/en/publications/establishing-priorities-for-psychological-interventions-in-pediatric-settings-a-decision-tree-approach-using-the-disabkids-10-index-as-a-screening-instrument 0.7 daily https://www.pchc.eu/en/publications/development-and-validation-of-the-patient-benefit-index-for-peripheral-arterial-disease 0.7 daily https://www.pchc.eu/en/publications/umsetzung-der-who-psoriasis-resolution-in-die-öffentlichkeit-ein-bundesweites-programm-gegen-stigmatisierung-bei-chronisch-sichtbaren-hauterkrankungen 0.7 daily https://www.pchc.eu/en/publications/translating-the-who-psoriasis-resolution-into-the-public-the-german-federal-program-against-stigmatization-2018-2020 0.7 daily https://www.pchc.eu/en/publications/do-children-adolescents-with-chronic-health-conditions-have-worse-hrqol-than-their-healthy-peers-a-meta-analysis-of-studies-using-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/en/publications/applications-of-the-kidcope-questionnaires-in-pediatric-settings-a-developmental-perspective-in-the-evaluation-of-coping-in-children-and-adolescents 0.7 daily https://www.pchc.eu/en/publications/quality-of-life-in-children-and-adolescents-with-short-stature-semantic-validation-and-pilot-study-of-the-portuguese-versions-of-the-qolissy-questionnaires 0.7 daily https://www.pchc.eu/en/publications/umsetzung-der-who-psoriasis-resolution-in-die-öffentlichkeit-ein-bundesweites-programm-gegen-stigmatisierung-bei-chronisch-sichtbaren-hauterkrankungen-2 0.7 daily https://www.pchc.eu/en/publications/hrqol-effects-of-growth-hormone-treatment-in-short-statured-youth-a-controlled-prospective-study 0.7 daily https://www.pchc.eu/en/publications/translating-the-who-psoriasis-resolution-into-the-public-the-german-federal-program-against-stigmatization-2018-2 0.7 daily https://www.pchc.eu/en/publications/the-assessment-of-pediatric-health-related-quality-of-life-in-eight-european-countries-using-disabkids-37-examining-differential-item-functioning-within-a-rasch-model-and-contrasting-outcomes 0.7 daily https://www.pchc.eu/en/publications/height-perception-of-children-with-gh-deficiency-influencing-factors-and-links-to-psychosocial-functioning 0.7 daily https://www.pchc.eu/en/publications/factors-influencing-health-related-quality-of-lfe-in-children-adolescents-with-growth-hormone-deficiency 0.7 daily https://www.pchc.eu/en/publications/cross-cultural-comparison-of-pediatric-asthma-related-quality-of-life-between-portugal-and-other-european-countries-measurement-invariance-and-differential-item-functioning-of-the-disabkids-asthma-module 0.7 daily https://www.pchc.eu/en/news-and-events/news/ddg-poster-award-disorders-of-the-pigmentary-system-2nd-prize 0.7 daily https://www.pchc.eu/en/news-and-events/news/hautkompass-wins-3rd-place-in-the-bvdd-innovation-award-2026 0.7 daily https://www.pchc.eu/en/news-and-events/news/we-are-nominated-for-the-msd-health-award-20250 0.7 daily https://www.pchc.eu/en/news-and-events/news/springer-nature-editor-of-distinction-awards-2025 0.7 daily https://www.pchc.eu/en/news-and-events/news/we-are-nominated-for-the-msd-health-award-2025 0.7 daily https://www.pchc.eu/en/news-and-events/news/hautkompass-on-german-tv 0.7 daily https://www.pchc.eu/en/news-and-events/news/we-are-nominated-for-the-msd-health-award-20256 0.7 daily https://www.pchc.eu/en/news-and-events/news/globalskin-conference-2025 0.7 daily https://www.pchc.eu/en/news-and-events/news/nationale-versorgungskonferenz-hidradenitis-suppurativa 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report6 0.7 daily https://www.pchc.eu/en/news-and-events/news/jeadv 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report 0.7 daily https://www.pchc.eu/en/news-and-events/news/symposium-of-the-bmbf-funded-junior-research-groups 0.7 daily https://www.pchc.eu/en/news-and-events/news/world-psoriasis-day-2024 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-dkvf-eadv-2024 0.7 daily https://www.pchc.eu/en/news-and-events/news/kongressbericht-dkvf-202372 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-dkvf-20233 0.7 daily https://www.pchc.eu/en/news-and-events/news/kongressbericht-dkvf-20237 0.7 daily https://www.pchc.eu/en/news-and-events/news/studienteilnehmer-hautkompass 0.7 daily https://www.pchc.eu/en/news-and-events/news/event-report-german-psoriasis-day-20235 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-eadv-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-dkvf-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/meeting-report-working-group-psychodermatology-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-ehps-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/psoriasis-academy-learning-zone 0.7 daily https://www.pchc.eu/en/news-and-events/news/conferene-report-esdap-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-ddg-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/announcement-ddg-2023 0.7 daily https://www.pchc.eu/en/news-and-events/news/cme-module-pchc 0.7 daily https://www.pchc.eu/en/news-and-events/news/announcement-eadv-2022 0.7 daily https://www.pchc.eu/en/news-and-events/news/conference-report-ehps-2022 0.7 daily https://www.pchc.eu/en/news-and-events/news/announcement-ehps-2022 0.7 daily https://www.pchc.eu/en/news-and-events/news/translation-who-video-pchc 0.7 daily https://www.pchc.eu/en/news-and-events/news/announcement-fobi-2022 0.7 daily https://www.pchc.eu/en/news-and-events/news/annual-meeting-of-the-deutsche-gesellschaft-für-psychosomatische-medizin-und-ärztliche-psychotherapie-dgpm-in-german 0.7 daily https://www.pchc.eu/en/news-and-events/news/eadv-webcast 0.7 daily https://www.pchc.eu/en/news-and-events/news/dpb-online-seminar 0.7 daily https://www.pchc.eu/en/news-and-events/news/call-for-participants 0.7 daily https://www.pchc.eu/en/news-and-events/events/kopra-2026 0.7 daily https://www.pchc.eu/en/news-and-events/events/akpsychderm-jahrestagung-2026 0.7 daily https://www.pchc.eu/en/news-and-events/events/am11 0.7 daily https://www.pchc.eu/en/news-and-events/events/esdap-2026 0.7 daily https://www.pchc.eu/en/news-and-events/events/open-question-webinar-on-alopecia-areata-and-hair-diseases-in-general 0.7 daily https://www.pchc.eu/en/news-and-events/events/8th-congress-of-the-skin-inflammation-psoriasis-international-network-spin 0.7 daily https://www.pchc.eu/en/news-and-events/events/dkvf-congress-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/esdap-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/dkpm-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/ehps-congress-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/ddg-tagung-2025 0.7 daily https://www.pchc.eu/en/news-and-events/events/fachsymposium-psychosomatik-und-psychotherapie 0.7 daily https://www.pchc.eu/en/news-and-events/events/isoqol-conference-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/german-psoriasis-day-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/ehps-congress-20237 0.7 daily https://www.pchc.eu/en/news-and-events/events/am10-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/ifpa-conference-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/dermatologisches-alpenseminar-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/dkvf-congress-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-13th-haut-update 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-dda-certification-course-ad2 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-psoriasis-day-information-sessio2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/webinar-hautupdate-spezial2024-september 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-registerveranstaltung2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/welt-vitiligo-tag-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/welt-neurodermitis-tag-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/webinar-hautupdate-spezial2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-tandem2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-haut-update-spezial2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-pso-certification-course-2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-haut-update-spezial-webinar2024 0.7 daily https://www.pchc.eu/en/news-and-events/events/vdbw-monday-colloquium-of-the-hamburg-occupational-physicians 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-10th-psonet-infladerm 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-11th-haut-update 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-11th-haut-update-spezial 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-dda-certification-course-ad 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-intensive-course-inflammatory-skin-diseases 0.7 daily https://www.pchc.eu/en/news-and-events/events/event-haut-update-spezial-webinar 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-2023 0.7 daily https://www.pchc.eu/en/news-and-events/events/dkvf-congress-2023 0.7 daily https://www.pchc.eu/en/news-and-events/events/ehps-congress-2023 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-202279 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-20227 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung72208 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7220 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung78 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-psoriasis-day-information-sessio2 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-atopic-eczema-day-information-session-in-german8 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-information-session-in-german2 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung767 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung76312 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7223 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7228 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-20228 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung72297 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-psoriasis-day-information-sessio9 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7631376 0.7 daily https://www.pchc.eu/en/news-and-events/events/informationsveranstaltung-über-menschenorientierte-versorgung-für-mitglieder-des-deutschen-psoriasis-bund-dpb7 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung76 0.7 daily https://www.pchc.eu/en/news-and-events/events/eadv-congress-2022 0.7 daily https://www.pchc.eu/en/news-and-events/events/jahrestagung-der-deutschen-gesellschaft-für-psychosomatische-medizin-und-ärztlichen-psychotherapie-2 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung763137 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7631 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7229 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung722 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung72 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-informationsveranstaltung7 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-psoriasis-day-information-sessio 0.7 daily https://www.pchc.eu/en/news-and-events/events/world-atopic-eczema-day-information-session-in-german 0.7 daily https://www.pchc.eu/en/news-and-events/events/acne-inversa-information-session-in-german 0.7 daily https://www.pchc.eu/en/news-and-events/events/information-session-on-people-centered-health-care-organized-by-the-deutsche-psoriasis-bund-dpb-in-german 1 daily https://www.pchc.eu/de/ 0.9 daily https://www.pchc.eu/de/unser-team 0.9 daily https://www.pchc.eu/de/forschungsthemen 0.9 daily https://www.pchc.eu/de/ressourcen 0.9 daily https://www.pchc.eu/de/publikationen 0.9 daily https://www.pchc.eu/de/neuigkeiten-events 0.9 daily https://www.pchc.eu/de/datenschutzrichtlinien 0.9 daily https://www.pchc.eu/de/impressum 0.8 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten 0.8 daily https://www.pchc.eu/de/ressourcen/unterrichtsmaterialien 0.8 daily https://www.pchc.eu/de/neuigkeiten-events/events 0.8 daily https://www.pchc.eu/de/ressourcen/instrumente-zur-erfassung-klinischer-und-patientenberichteter-endpunkte-cros-pros 0.7 daily https://www.pchc.eu/de/unser-team/dr-caroline-f-z-stuhlmann 0.7 daily https://www.pchc.eu/de/unser-team/khadija-rudloff 0.7 daily https://www.pchc.eu/de/unser-team/marielle-donié-m-sc 0.7 daily https://www.pchc.eu/de/unser-team/juliane-traxler-m-sc 0.7 daily https://www.pchc.eu/de/unser-team/sophie-kiesewetter 0.7 daily https://www.pchc.eu/de/unser-team/dr-neuza-da-silva-burger 0.7 daily https://www.pchc.eu/de/unser-team/dr-catharina-braren-von-stülpnagel-m-sc 0.7 daily https://www.pchc.eu/de/unser-team/pd-dr-rachel-sommer 0.7 daily https://www.pchc.eu/de/unser-team/lukas-westphal-m-sc 0.7 daily https://www.pchc.eu/de/unser-team/prof-dr-matthias-augustin 0.7 daily https://www.pchc.eu/de/forschungsthemen/patientenberichtete-und-klinische-endpunkte 0.7 daily https://www.pchc.eu/de/forschungsthemen/erfassung-der-krankheitslast-und-der-bedürfnisse-von-patient-innen 0.7 daily https://www.pchc.eu/de/forschungsthemen/behandlungseffekte 0.7 daily https://www.pchc.eu/de/forschungsthemen/interventionen 0.7 daily https://www.pchc.eu/de/forschungsthemen/stigmatisierung 0.7 daily https://www.pchc.eu/de/forschungsthemen/kumulative-beeinträchtigung-im-lebensverlauf 0.7 daily https://www.pchc.eu/de/publikationen/testing-undergraduate-medical-students-ability-to-correctly-identify-skin-conditions-in-skin-of-color-a-pre-post-study-at-a-medical-school-in-germany 0.7 daily https://www.pchc.eu/de/publikationen/well-being-in-german-patients-with-vitiligo-in-genital-and-visible-areas-a-pilot-study 0.7 daily https://www.pchc.eu/de/publikationen/prevalence-of-genital-psoriasis-and-its-impact-on-patients-sexual-life-in-routine-care-epidemiologic-survey-in-germany 0.7 daily https://www.pchc.eu/de/publikationen/validation-of-the-german-version-of-infants-and-toddlers-dermatology-quality-of-life-intodermqol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/iwell-being-in-german-patients-with-vitiligo-in-genital-and-visible-areas-a-pilot-study 0.7 daily https://www.pchc.eu/de/publikationen/psychosoziale-gesundheit-und-vitiligo-in-deutschland-was-wollen-wir-wissen-und-wozu 0.7 daily https://www.pchc.eu/de/publikationen/erfassung-der-lebensqualität-bei-säuglingen-und-kleinkindern-mit-hauterkrankungen-validierung-des-deutschen-intodermqol-fragebogens4 0.7 daily https://www.pchc.eu/de/publikationen/analyse-des-neuen-derm-clci-r-fragebogens-zur-erfassung-kumulierender-krankheitsbelastungen-bei-patienten-mit-atopischer-dermatitis 0.7 daily https://www.pchc.eu/de/publikationen/cumulative-life-course-impairment-clci-messung-der-kumulierenden-lebensbelastungen-bei-patienten-mit-psoriasis-in-der-routineversorgung-mit-einem-validierten-instrument 0.7 daily https://www.pchc.eu/de/publikationen/the-global-research-on-the-impact-of-dermatological-diseases-gridd-in-germany 0.7 daily https://www.pchc.eu/de/publikationen/communication-and-therapy-planning-for-patients-of-reproductive-age-under-immunomodulatory-treatments-for-psoriasis-or-psoriatic-arthritis-survey-of-the-german-national-psoriasis-registry-psobest 0.7 daily https://www.pchc.eu/de/publikationen/version-of-the-family-dermatology-life-quality-index-f-dlqi 0.7 daily https://www.pchc.eu/de/publikationen/patient-reported-well-being-in-value-based-routine-care-using-tildrakizumab-52-week-interim-data-of-the-phase-iv-positive-study5 0.7 daily https://www.pchc.eu/de/publikationen/erfassung-der-lebensqualität-bei-säuglingen-und-kleinkindern-mit-hauterkrankungen-validierung-des-deutschen-intodermqol-fragebogens41 0.7 daily https://www.pchc.eu/de/publikationen/interdisciplinary-care-in-immune-mediated-inflammatory-diseases-with-skin-manifestations-within-the-who-s-people-centred-healthcare-framework 0.7 daily https://www.pchc.eu/de/publikationen/effectiveness-of-a-self-compassion-programme-to-reduce-self-stigma-in-chronic-skin-diseases-the-hautkompass-rct 0.7 daily https://www.pchc.eu/de/publikationen/wirksamkeit-des-online-programms-hautkompass 0.7 daily https://www.pchc.eu/de/publikationen/family-dermatology-life-quality-index-f-dlqi-german-validation-and-applicability-to-parents-of-infants-and-toddlers-with-dermatological-conditions 0.7 daily https://www.pchc.eu/de/publikationen/effectiveness-of-a-self-compassion-programme-to-reduce-self-stigma-in-chronic-skin-diseases-the-hautkompass-rct8 0.7 daily https://www.pchc.eu/de/publikationen/erfassung-der-lebensqualität-bei-säuglingen-und-kleinkindern-mit-hauterkrankungen-validierung-des-deutschen-intodermqol-fragebogens 0.7 daily https://www.pchc.eu/de/publikationen/efficacy-of-an-intervention-to-reduce-stigma-towards-people-with-skin-diseases-among-health-and-body-care-professionals-a-randomized-controlled-trial 0.7 daily https://www.pchc.eu/de/publikationen/responsiveness-and-minimally-important-change-of-the-patient-reported-impact-of-dermatological-diseases-pridd-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/implementation-of-a-team-teaching-seminar-on-the-stigmatization-and-psychosocial-burdens-of-people-with-visible-skin-diseases-in-the-standard-curriculum-of-medical-studies 0.7 daily https://www.pchc.eu/de/publikationen/vitiligo-im-dialog-die-plenumsdiskussion 0.7 daily https://www.pchc.eu/de/publikationen/communication-and-treatment-planning-in-reproductive-age-psoriasis-patients-undergoing-immunomodulatory-therapy-a-survey-in-the-german-psoriasis-registry-psobest 0.7 daily https://www.pchc.eu/de/publikationen/assessing-quality-of-life-in-infants-and-toddlers-with-dermatological-conditions-validation-of-the-intodermqol-questionnaire-german-version 0.7 daily https://www.pchc.eu/de/publikationen/patient-reported-impact-of-dermatological-diseases-and-mental-health 0.7 daily https://www.pchc.eu/de/publikationen/version-of-the-family-dermatology-life-quality-index-f-dlqi6 0.7 daily https://www.pchc.eu/de/publikationen/patient-reported-impact-of-dermatological-diseases-and-mental-health6 0.7 daily https://www.pchc.eu/de/publikationen/skin-love-entwicklung-und-anwendung-einer-methodik-zur-charakterisierung-des-emotionalen-verhältnisses-mit-der-haut 0.7 daily https://www.pchc.eu/de/publikationen/reducing-self-stigma-and-fostering-acceptance-in-people-living-with-chronic-skin-disease-through-an-online-program-results-of-the-hautkompass-rct 0.7 daily https://www.pchc.eu/de/publikationen/effectiveness-of-the-hautkompass-online-programme-in-reducing-self-stigma-in-people-with-chronic-skin-diseases-a-randomized-controlled-trial 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis46076 0.7 daily https://www.pchc.eu/de/publikationen/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis2 0.7 daily https://www.pchc.eu/de/publikationen/growth-hormone-treatment-in-children-with-short-stature-impact-of-the-diagnosis-on-parents2 0.7 daily https://www.pchc.eu/de/publikationen/growth-hormone-treatment-in-children-with-short-stature-impact-of-the-diagnosis-on-parents 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis4607 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis460 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8395 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis46 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review839 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review54 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review83 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review5 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8396 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review8 0.7 daily https://www.pchc.eu/de/publikationen/identifying-predictors-and-correlates-of-skin-disease-self-stigma-for-online-rct-intervention-a-systematic-review547 0.7 daily https://www.pchc.eu/de/publikationen/a-comparative-analysis-of-the-predictors-extent-and-impacts-of-self-stigma-in-patients-with-psoriasis-and-atopic-dermatitis 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis4 0.7 daily https://www.pchc.eu/de/publikationen/4how-do-dermatologists-personal-models-inform-a-patient-centred-approach-to-management-a-qualitative-study-using-the-example-of-prescribing-a-new-treatment-apremilast 0.7 daily https://www.pchc.eu/de/publikationen/acad-dermatol-venereol-2021-sommer-development-and-validation-of-an-outcome-instrument-measuring-dry-skin-the-xerosis-area-and-severity-index-xasi5 0.7 daily https://www.pchc.eu/de/publikationen/parents-with-asthmatic-children-quality-of-life 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire1 0.7 daily https://www.pchc.eu/de/publikationen/development-and-validation-of-an-outcome-instrument-measuring-dry-skin-the-xerosis-area-and-severity-index-xasi 0.7 daily https://www.pchc.eu/de/publikationen/psychometric-properties-of-the-short-version-of-the-freiburg-life-quality-assessment-for-chronic-venous-disease 0.7 daily https://www.pchc.eu/de/publikationen/is-social-stigma-responsible-for-the-poor-psychological-adjustment-of-people-with-visible-skin-disease-a-meta-analysis 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire7 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire73 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire14 0.7 daily https://www.pchc.eu/de/publikationen/measuring-patient-relevant-benefits-in-the-treatment-of-psoriasis-with-the-patient-benefit-index-development-and-preliminary-validation-of-a-10-item-short-form 0.7 daily https://www.pchc.eu/de/publikationen/dermatological-care-of-elderly-people-with-psoriasis-before-and-after-entering-a-nursing-home-a-qualitative-analysis-from-the-perspective-of-medical-providers 0.7 daily https://www.pchc.eu/de/publikationen/measuring-wellbeing-in-psoriasis-psychometric-properties-of-the-who-5-questionnaire144 0.7 daily https://www.pchc.eu/de/publikationen/interpersonal-experiences-of-stigmatization-and-sexual-impairments-quality-of-life-and-depression-in-patients-with-psoriasis-the-mediating-role-of-social-avoidance-coping 0.7 daily https://www.pchc.eu/de/publikationen/secukinumab-effects-on-patient-reported-outcomes-in-plaque-psoriasis-across-europe-data-from-the-prose-study 0.7 daily https://www.pchc.eu/de/publikationen/validation-of-the-spanish-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/disease-burden-and-patient-needs-benefits-in-patients-with-psoriasis-with-and-without-anogenital-involvement-preliminary-results-from-the-psogen-study 0.7 daily https://www.pchc.eu/de/publikationen/stigma-in-visible-skin-diseases-a-literature-review-and-development-of-a-conceptual-model 0.7 daily https://www.pchc.eu/de/publikationen/effectiveness-of-a-structured-short-intervention-against-stigmatisation-in-chronic-visible-skin-diseases-results-of-a-controlled-trial-in-future-educators 0.7 daily https://www.pchc.eu/de/publikationen/secukinumab-effects-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-perspective-data-from-the-prose-study 0.7 daily https://www.pchc.eu/de/publikationen/assessment-of-stigma-related-to-visible-skin-diseases-a-systematic-review-and-evaluation-of-patient-reported-outcome-measures 0.7 daily https://www.pchc.eu/de/publikationen/exploring-the-burden-of-xerosis-cutis-and-the-impact-of-dermatological-skin-care-from-patient-s-perspective 0.7 daily https://www.pchc.eu/de/publikationen/patient-reported-outcomes-measures-measuring-wellbeing-not-only-burden-of-disease 0.7 daily https://www.pchc.eu/de/publikationen/mapping-risk-factors-for-cumulative-life-course-impairment-in-patients-with-chronic-skin-diseases-a-systematic-review 0.7 daily https://www.pchc.eu/de/publikationen/disease-severity-and-patient-needs-benefits-in-genital-psoriasis-patient-reported-improvement-after-6-1-months-of-apremilast-treatment 0.7 daily https://www.pchc.eu/de/publikationen/psychosocial-function-of-vitiligo-patients-in-the-face-of-stigmatization-a-systematic-review 0.7 daily https://www.pchc.eu/de/publikationen/determining-the-minimal-important-difference-for-the-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/effects-of-secukinumab-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-s-perspective-data-from-the-prose-study 0.7 daily https://www.pchc.eu/de/publikationen/klinische-studien-teil-1-daten-und-ergebnisse-besser-verstehen 0.7 daily https://www.pchc.eu/de/publikationen/bestimmung-der-transnationalen-gesundheitsbezogenen-lebensqualität-die-kulturübergreifende-validität-des-überarbeiteten-wound-qol-fragebogens 0.7 daily https://www.pchc.eu/de/publikationen/klinische-studien-teil-1-daten-und-ergebnisse-besser-verstehen8 0.7 daily https://www.pchc.eu/de/publikationen/skin-lesions-skin-care-and-characteristics-of-pruritus-in-patients-undergoing-haemodialysis 0.7 daily https://www.pchc.eu/de/publikationen/topologie-der-psoriasis-eine-prävalenzanalyse-aus-real-world-daten-im-längs-und-querschnitt 0.7 daily https://www.pchc.eu/de/publikationen/the-importance-of-patient-centered-healthcare-against-comorbid-depression-and-anxiety-in-patients-with-psoriasis 0.7 daily https://www.pchc.eu/de/publikationen/patients-and-physicians-perspectives-on-body-surface-area-affected-by-psoriasis-links-between-disease-burden-patient-physician-dis-agreement-and-patient-benefits 0.7 daily https://www.pchc.eu/de/publikationen/cumulative-life-course-impairment-systematisches-review-zur-bestimmung-von-indikatoren 0.7 daily https://www.pchc.eu/de/publikationen/assessing-the-quality-of-life-of-people-with-chronic-wounds-by-using-the-cross-culturally-valid-and-revised-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/significance-of-chronic-pruritus-for-intrapersonal-burden-and-interpersonal-experiences-of-stigmatization-and-sexuality-in-patients-with-psoriasis 0.7 daily https://www.pchc.eu/de/publikationen/xerosis-cutis-und-stigmatisierung-patientensicht-bei-hauterkrankungen-und-erkenntnisse-über-die-auswirkungen-einer-hautpflege 0.7 daily https://www.pchc.eu/de/publikationen/was-wünschen-sich-patienten-mit-sichtbaren-hauterkrankungen-und-welche-probleme-beschäftigen-sie-im-alltag 0.7 daily https://www.pchc.eu/de/publikationen/instrumentenentwicklung-und-bewertung-bestimmung-der-transnationalen-gesundheitsbezogenen-lebensqualität-die-kulturübergreifende-validität-des-überarbeiteten-wound-qol-fragebogens 0.7 daily https://www.pchc.eu/de/publikationen/impact-of-moderate-to-severe-pruritus-in-patients-with-psoriasis-association-between-disease-burden-patient-needs-and-interpersonal-experiences 0.7 daily https://www.pchc.eu/de/publikationen/umsetzung-der-wha-resolution-in-deutschland-entwicklung-erprobung-und-evaluation-von-interventionen-zur-entstigmatisierung-von-menschen-mit-sichtbaren-chronischen-hauterkrankungen 0.7 daily https://www.pchc.eu/de/publikationen/translating-the-wha-resolution-in-a-member-state-development-testing-and-evaluation-of-interventions-against-stigmatization-of-people-with-visible-skin-diseases 0.7 daily https://www.pchc.eu/de/publikationen/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/xerosis-cutis-weit-mehr-als-nur-trockene-haut 0.7 daily https://www.pchc.eu/de/publikationen/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire-2 0.7 daily https://www.pchc.eu/de/publikationen/perception-and-determinants-of-stigmatization-of-people-with-psoriasis-in-the-german-population 0.7 daily https://www.pchc.eu/de/publikationen/characterizing-treatment-related-patient-needs-in-atopic-eczema-insights-for-personalized-goal-orientation 0.7 daily https://www.pchc.eu/de/publikationen/nice-kids-healthy-kids-prosocial-behavior-psychological-problems-and-quality-of-life-in-children-preadolescents-and-adolescents-with-and-without-chronic-health-conditions 0.7 daily https://www.pchc.eu/de/publikationen/portuguese-version-of-the-disabkids-diabetes-module 0.7 daily https://www.pchc.eu/de/publikationen/gesundheitsökonomie-und-personenzentrierte-versorgung-chronischer-wunden-in-deutschland 0.7 daily https://www.pchc.eu/de/publikationen/instrumentenentwicklung-und-bewertung-bestimmung-der-transnationalen-gesundheitsbezogenen-lebensqualität-die-kulturübergreifende-validität-des-überarbeiteten-wound-qol-fragebogens 0.7 daily https://www.pchc.eu/de/publikationen/impact-of-moderate-to-severe-pruritus-in-patients-with-psoriasis-association-between-disease-burden-patient-needs-and-interpersonal-experiences 0.7 daily https://www.pchc.eu/de/publikationen/umsetzung-der-wha-resolution-in-deutschland-entwicklung-erprobung-und-evaluation-von-interventionen-zur-entstigmatisierung-von-menschen-mit-sichtbaren-chronischen-hauterkrankungen 0.7 daily https://www.pchc.eu/de/publikationen/translating-the-wha-resolution-in-a-member-state-development-testing-and-evaluation-of-interventions-against-stigmatization-of-people-with-visible-skin-diseases 0.7 daily https://www.pchc.eu/de/publikationen/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/xerosis-cutis-weit-mehr-als-nur-trockene-haut 0.7 daily https://www.pchc.eu/de/publikationen/assessing-hrqol-in-chronic-wounds-across-countries-the-cross-cultural-validity-of-the-revised-wound-qol-questionnaire-2 0.7 daily https://www.pchc.eu/de/publikationen/body-height-or-height-related-cognitive-beliefs-what-matters-the-most-for-the-health-related-quality-of-life-of-children-and-adolescents-with-short-stature 0.7 daily https://www.pchc.eu/de/publikationen/disease-severity-and-patient-needs-benefits-in-genital-psoriasis-patient-reported-improvement-after-6-1-months-of-apremilast-treatment-2 0.7 daily https://www.pchc.eu/de/publikationen/effects-of-secukinumab-on-disease-burden-patient-needs-and-benefits-and-treatment-satisfaction-in-patients-with-plaque-psoriasis-across-european-regions-patient-s-perspective-data-from-the-prose-study-2 0.7 daily https://www.pchc.eu/de/publikationen/psychological-co-morbidity-in-patients-with-and-without-anogenital-psoriasis-and-chronic-pruritus-associations-between-disease-treatment-burden-and-clinically-significant-symptoms-of-depression-and-anxiety 0.7 daily https://www.pchc.eu/de/publikationen/patient-physician-dis-agreement-on-their-reports-of-body-surface-area-affected-by-psoriasis-associations-with-disease-burden-and-patient-defined-treatment-benefits 0.7 daily https://www.pchc.eu/de/publikationen/xerosis-cutis-and-stigmatization-exploring-patient-s-view-of-skin-affections-and-impact-of-skin-care 0.7 daily https://www.pchc.eu/de/publikationen/development-and-psychometric-evaluation-of-the-u-s-english-wound-qol-questionnaire-to-assess-health-related-quality-of-life-in-people-with-chronic-wounds-2 0.7 daily https://www.pchc.eu/de/publikationen/psychological-comorbidity-in-patients-with-psoriasis-the-impact-of-pruritus-and-anogenital-involvement-on-symptoms-of-depression-and-anxiety 0.7 daily https://www.pchc.eu/de/publikationen/cumulative-life-course-impairment-systematisches-review-zur-bestimmung-von-indikatoren-2 0.7 daily https://www.pchc.eu/de/publikationen/xerosis-cutis-und-stigmatisierung-patientensicht-bei-hauterkrankungen-und-erkenntnisse-über-die-auswirkungen-einer-hautpflege-2 0.7 daily https://www.pchc.eu/de/publikationen/impact-of-pruritus-in-patients-with-psoriasis-associations-between-disease-burden-patient-needs-and-interpersonal-experiences 0.7 daily https://www.pchc.eu/de/publikationen/epidemiology-and-dermatological-comorbidity-of-seborrhoeic-dermatitis-population-based-study-in-161-269-employees 0.7 daily https://www.pchc.eu/de/publikationen/stigmatisierungserleben-bei-psoriasis-qualitative-analyse-aus-sicht-von-betroffenen-angehörigen-und-versorgern-perception-of-stigmatization-in-people-with-psoriasis-qualitative-analysis-from-the-perspective-of-patients-relatives-and-healthcare-professionals 0.7 daily https://www.pchc.eu/de/publikationen/cross-cultural-selection-and-validation-of-instruments-to-assess-patient-reported-outcomes-in-children-and-adolescents-with-achondroplasia 0.7 daily https://www.pchc.eu/de/publikationen/gender-and-age-significantly-determine-patient-needs-and-treatment-goals-in-psoriasis-a-lesson-for-practice 0.7 daily https://www.pchc.eu/de/publikationen/topology-of-psoriasis-in-routine-care-results-from-high-resolution-analysis-of-2009-patients 0.7 daily https://www.pchc.eu/de/publikationen/strategies-to-reduce-stigma-related-to-visible-chronic-skin-diseases-a-systematic-review 0.7 daily https://www.pchc.eu/de/publikationen/health-related-quality-of-life-experiences-in-children-and-adolescents-born-with-esophageal-atresia-a-swedish-german-focus-group-study 0.7 daily https://www.pchc.eu/de/publikationen/piloting-and-psychometric-properties-of-a-patient-reported-outcome-instrument-for-young-people-with-achondroplasia-based-on-the-international-classification-of-functioning-disability-and-health-the-achondroplasia-personal-life-experience-scale-aples 0.7 daily https://www.pchc.eu/de/publikationen/translating-the-wha-resolution-in-a-member-state-towards-a-german-programme-on-destigmatization-for-individuals-with-visible-chronic-skin-diseases 0.7 daily https://www.pchc.eu/de/publikationen/psychometric-properties-of-the-quality-of-life-in-short-statured-youth-qolissy-questionnaire-within-the-course-of-growth-hormone-treatment 0.7 daily https://www.pchc.eu/de/publikationen/quality-of-life-of-short-statured-children-born-small-for-gestational-age-or-idiopathic-growth-hormone-deficiency-within-1-year-of-growth-hormone-treatment 0.7 daily https://www.pchc.eu/de/publikationen/validation-of-the-greek-version-of-quality-of-life-in-short-stature-youth-qolissy-questionnaire 0.7 daily https://www.pchc.eu/de/publikationen/first-year-predictors-of-health-related-quality-of-life-changes-in-short-statured-children-treated-with-human-growth-hormone 0.7 daily https://www.pchc.eu/de/publikationen/do-8-to-18-year-old-children-adolescents-with-chronic-physical-health-conditions-have-worse-health-related-quality-of-life-than-their-healthy-peers-a-meta-analysis-of-studies-using-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/de/publikationen/ökonomie-der-wundversorgung-in-dissemond 0.7 daily https://www.pchc.eu/de/publikationen/sex-related-impairments-and-patient-needs-in-ano-genital-psoriasis-difficult-to-communicate-topics-and-their-impact-on-patient-centred-care 0.7 daily https://www.pchc.eu/de/publikationen/identifying-specific-patient-needs-and-treatment-goals-in-chronic-spontaneous-urticaria-for-a-patient-centered-clinical-decision-making-process 0.7 daily https://www.pchc.eu/de/publikationen/significance-and-extent-of-stigmatization-against-persons-with-visible-skin-conditions-in-the-public 0.7 daily https://www.pchc.eu/de/publikationen/wahrnehmung-und-prädiktoren-von-vorurteilen-bei-menschen-mit-psoriasis 0.7 daily https://www.pchc.eu/de/publikationen/disease-burden-and-patient-needs-related-to-sensitive-body-areas-in-patients-with-psoriasis-results-from-routine-care 0.7 daily https://www.pchc.eu/de/publikationen/characterising-treatment-related-patient-needs-in-atopic-eczema-insights-for-personalised-goal-orientation 0.7 daily https://www.pchc.eu/de/publikationen/characterizing-treatment-related-patient-needs-in-atopic-dermatitis-insights-for-personalized-goal-orientation 0.7 daily https://www.pchc.eu/de/publikationen/perception-of-stigmatization-of-people-with-psoriasis-a-qualitative-analyses-from-patients-perspective-their-relatives-and-health-care-providers 0.7 daily https://www.pchc.eu/de/publikationen/merkmale-und-determinanten-von-patientenbedarfen-bei-der-behandlung-von-chronisch-spontaner-urtikaria 0.7 daily https://www.pchc.eu/de/publikationen/krankheitsbelastung-und-patientenbedarfe-in-bezug-auf-sensible-körperregionen-bei-patienten-mit-psoriasis-ergebnisse-aus-der-routineversorgung 0.7 daily https://www.pchc.eu/de/publikationen/hautläsionen-hautpflege-und-eigenschaften-von-juckreiz-bei-patienten-mit-urämie-nach-hämodialyse 0.7 daily https://www.pchc.eu/de/publikationen/quality-of-life-profile-in-children-adolescents-with-chronic-conditions-a-meta-analysis-with-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/de/publikationen/disease-burden-and-patient-needs-in-emerging-adults-and-adults-with-psoriasis-addressing-developmental-specificities-for-person-centered-healthcare 0.7 daily https://www.pchc.eu/de/publikationen/skin-disease-implications-for-self-image-development-in-adolescence-and-young-adulthood 0.7 daily https://www.pchc.eu/de/publikationen/erste-daten-und-strategien-zur-entstigmatisierung 0.7 daily https://www.pchc.eu/de/publikationen/people-centered-health-care-von-clci-bis-entstigmatisierung-neue-versorgungskonzepte-bei-hauterkrankungen 0.7 daily https://www.pchc.eu/de/publikationen/leitliniengerechte-behandlung-adhärenz-präferenz 0.7 daily https://www.pchc.eu/de/publikationen/keeping-a-pro-instrument-alive-the-international-pediatric-disabkids-initiative 0.7 daily https://www.pchc.eu/de/publikationen/topology-of-psoriasis-in-sexually-sensitive-and-visible-body-areas-disease-burden-and-patient-needs-in-routine-care 0.7 daily https://www.pchc.eu/de/publikationen/sex-related-impairments-and-patient-needs-in-anogenital-psoriasis-difficult-to-communicate-topics-and-their-impact-on-patient-centred-care 0.7 daily https://www.pchc.eu/de/publikationen/people-centered-health-care-pchc-a-new-concept-for-characterizing-comprehensive-effective-care-in-dermatology 0.7 daily https://www.pchc.eu/de/publikationen/patient-needs-and-treatment-goals-in-atopic-eczema-insights-for-patient-centered-routine-care 0.7 daily https://www.pchc.eu/de/publikationen/cumulative-life-course-impairment-clci-a-concept-supporting-people-centered-care-in-dermatology 0.7 daily https://www.pchc.eu/de/publikationen/perception-and-predictors-of-prejudice-in-people-with-psoriasis-in-the-german-population 0.7 daily https://www.pchc.eu/de/publikationen/disease-burden-related-to-sensitive-body-areas-in-patients-with-psoriasis-results-from-large-scale-studies-in-routine-care 0.7 daily https://www.pchc.eu/de/publikationen/characteristics-and-determinants-of-patient-burden-and-needs-in-the-treatment-of-chronic-spontaneous-urticarial 0.7 daily https://www.pchc.eu/de/publikationen/cumulative-life-course-impairment-clci-ein-konstrukt-zur-unterstützung-der-personenzentrierten-gesundheitsversorgung-bei-chronischen-hautkrankheiten 0.7 daily https://www.pchc.eu/de/publikationen/charakterisierung-der-behandlungsbezogenen-patientenbedürfnisse-bei-neurodermitis-einblicke-in-eine-personenzentrierte-zielorientierung 0.7 daily https://www.pchc.eu/de/publikationen/entwicklung-und-umsetzung-des-bmg-förderprojektes-zur-entstigmatisierung-bei-menschen-mit-sichtbaren-chronischen-hautkrankheiten-auf-basis-des-who-berichts-zu-psoriasis 0.7 daily https://www.pchc.eu/de/publikationen/wahrnehmung-der-stigmatisierung-von-menschen-mit-psoriasis-eine-qualitative-analyse-aus-patientensicht-deren-angehörigen-und-leistungserbringern 0.7 daily https://www.pchc.eu/de/publikationen/people-centered-health-care-pchc-in-der-dermatologie-ansätze-für-eine-versorgung-im-rahmen-der-who-forderung 0.7 daily https://www.pchc.eu/de/publikationen/maßnahmen-zum-abbau-von-stigmatisierung-und-ausgrenzung-von-menschen-mit-chronischen-hauterkrankungen-ergebnisse-einer-pilot-intervention-bei-jugendlichen 0.7 daily https://www.pchc.eu/de/publikationen/same-language-different-culture-differential-item-functioning-and-factor-structure-of-the-disabkids-37-questionnaire-in-portuguese-and-brazilian-children-adolescents-with-asthma-and-diabetes 0.7 daily https://www.pchc.eu/de/publikationen/differences-between-patient-and-proxy-reported-hrqol-using-the-wound-qol 0.7 daily https://www.pchc.eu/de/publikationen/versorgungsforschung-in-der-dermatologie-2018-kraft-des-faktischen-was-versorgungsforschung-ist-und-wem-sie-dient 0.7 daily https://www.pchc.eu/de/publikationen/differences-between-patient-and-proxy-reported-hrqol-using-the-wound-qol-2 0.7 daily https://www.pchc.eu/de/publikationen/schuppenflechte-oder-psoriasis-wortwahl-und-bekanntheit-der-fachbegriffe-in-der-öffentlichkeit 0.7 daily https://www.pchc.eu/de/publikationen/what-is-psoriasis-perception-and-assessment-of-psoriasis-among-the-german-population 0.7 daily https://www.pchc.eu/de/publikationen/was-ist-schuppenflechte-wahrnehmung-und-bewertung-der-psoriasis-in-der-deutschen-bevölkerung 0.7 daily https://www.pchc.eu/de/publikationen/quality-of-life-in-adolescent-boys-with-idiopathic-short-stature-positive-impact-of-growth-hormone-and-aromatase-inhibitors 0.7 daily https://www.pchc.eu/de/publikationen/children-s-psychosocial-functioning-and-parents-quality-of-life-in-paediatric-short-stature-the-mediating-role-of-caregiving-stress 0.7 daily https://www.pchc.eu/de/publikationen/the-psychometric-evaluation-of-the-quality-of-life-in-short-stature-youth-qolissy-instrument-for-german-children-born-small-for-gestational-age 0.7 daily https://www.pchc.eu/de/publikationen/establishing-priorities-for-psychological-interventions-in-pediatric-settings-a-decision-tree-approach-using-the-disabkids-10-index-as-a-screening-instrument 0.7 daily https://www.pchc.eu/de/publikationen/development-and-validation-of-the-patient-benefit-index-for-peripheral-arterial-disease 0.7 daily https://www.pchc.eu/de/publikationen/umsetzung-der-who-psoriasis-resolution-in-die-öffentlichkeit-ein-bundesweites-programm-gegen-stigmatisierung-bei-chronisch-sichtbaren-hauterkrankungen 0.7 daily https://www.pchc.eu/de/publikationen/translating-the-who-psoriasis-resolution-into-the-public-the-german-federal-program-against-stigmatization-2018-2020 0.7 daily https://www.pchc.eu/de/publikationen/do-children-adolescents-with-chronic-health-conditions-have-worse-hrqol-than-their-healthy-peers-a-meta-analysis-of-studies-using-the-kidscreen-questionnaires 0.7 daily https://www.pchc.eu/de/publikationen/applications-of-the-kidcope-questionnaires-in-pediatric-settings-a-developmental-perspective-in-the-evaluation-of-coping-in-children-and-adolescents 0.7 daily https://www.pchc.eu/de/publikationen/quality-of-life-in-children-and-adolescents-with-short-stature-semantic-validation-and-pilot-study-of-the-portuguese-versions-of-the-qolissy-questionnaires 0.7 daily https://www.pchc.eu/de/publikationen/translating-the-who-psoriasis-resolution-into-the-public-the-german-federal-program-against-stigmatization-2018-2 0.7 daily https://www.pchc.eu/de/publikationen/umsetzung-der-who-psoriasis-resolution-in-die-öffentlichkeit-ein-bundesweites-programm-gegen-stigmatisierung-bei-chronisch-sichtbaren-hauterkrankungen-2 0.7 daily https://www.pchc.eu/de/publikationen/hrqol-effects-of-growth-hormone-treatment-in-short-statured-youth-a-controlled-prospective-study 0.7 daily https://www.pchc.eu/de/publikationen/the-assessment-of-pediatric-health-related-quality-of-life-in-eight-european-countries-using-disabkids-37-examining-differential-item-functioning-within-a-rasch-model-and-contrasting-outcomes 0.7 daily https://www.pchc.eu/de/publikationen/height-perception-of-children-with-gh-deficiency-influencing-factors-and-links-to-psychosocial-functioning 0.7 daily https://www.pchc.eu/de/publikationen/factors-influencing-health-related-quality-of-lfe-in-children-adolescents-with-growth-hormone-deficiency 0.7 daily https://www.pchc.eu/de/publikationen/cross-cultural-comparison-of-pediatric-asthma-related-quality-of-life-between-portugal-and-other-european-countries-measurement-invariance-and-differential-item-functioning-of-the-disabkids-asthma-module 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/ddg-posterpreis-erkrankungen-des-pigmentsystems-2-preis 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/hautkompass-gewinnt-den-3-platz-beim-bvdd-innovationspreis-2026 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/we-are-nominated-for-the-msd-health-award-20250 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/springer-nature-editor-of-distinction-awards-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/wir-sind-nominiert-für-den-msd-gesundheitspreis-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/hautkompass-beim-ndr-beitrag-in-der-sendung-das 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/we-are-nominated-for-the-msd-health-award-20256 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/globalskin-conference-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/nationale-versorgungskonferenz-hidradenitis-suppurativa 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/conference-report6 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/jeadv 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/conference-report 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/symposium-der-bmbf-nachwuchsgruppe 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/welt-psoriasis-tag-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/konferenzbericht-dkvf-eadv-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/konferenzbericht-ehps-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/welt-vitiligo-tag-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-dkvf-20237 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/studienteilnehmer-innen-gesucht 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/studienteilnehmer-hautkompass 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/veranstaltungsbericht-deutscher-psoriasis-tag-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-eadv-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-dkvf-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/bericht-10-psonet-infladerm 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-ehps-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/psoriasis-academy-learning-zone 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-esdap-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-ddg-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/ankuendigung-ddg-2023 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/cme-modul 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/ankuendigung-eadv-2022 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/kongressbericht-ehps-2022 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/ankuendigung-ehps-2022 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/übersetzung-who-video-pchc 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/ankuendigung-fobi-2022 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/jahrestagung-der-deutschen-gesellschaft-für-psychosomatische-medizin-und-ärztlichen-psychotherapie 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/eadv-webcast 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/neuigkeiten/online-seminar-menschenorientiere-versorgungsforschung 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/am11 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/kopra-2026 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/akpsychderm-jahrestagung-2026 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/esdap-2026 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/offenes-fragen-webinar-zu-alopecia-areata-und-haarerkrankungen-allgemein 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/8-kongress-des-skin-inflammation-psoriasis-international-network-spin 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/dkvf-congress-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/esdap-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/dkpm-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/ehps-congress-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/ddg-tagung-2025 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/fachsymposium-psychosomatik-und-psychotherapie 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/isoqol-conference-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/deutscher-psoriasis-tag-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/ehps-congress-20237 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/am10-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/ifpa-conference-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/dermatologisches-alpenseminar-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/dkvf-kongress-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-13th-haut-update 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-dda-certification-course-ad2 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/world-psoriasis-day-information-sessio2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/webinar-hautupdate-spezial2024-september 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-registerveranstaltung2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-vitiligo-tag-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-neurodermitis-tag-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/webinar-hautupdate-spezial2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-tandem2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-haut-update-spezial2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-pso-certification-course-2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-haut-update-spezial-webinar2024 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/vdbw-montagskolloquium-der-hamburger-arbeitsmediziner 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-10th-psonet-infladerm 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-haut-update-spezial 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-11-haut-update 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/event-intensivkurs-entzuendliche-hautkrankheiten 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung763189 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung722084 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-20223 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-202288 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-2022793 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-202279 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-20227 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-neurodermitis-tag-informationsveranstaltung1 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-psoriasis-tag-informationsveranstaltung5 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung9 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung760 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung76318 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung785 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung72208 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung78 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung7228 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-20228 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung72297 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/world-psoriasis-day-information-sessio9 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung7631376 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/informationsveranstaltung-über-menschenorientierte-versorgung-für-mitglieder-des-deutschen-psoriasis-bund-dpb7 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/eadv-congress-2022 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/jahrestagung-der-deutschen-gesellschaft-für-psychosomatische-medizin-und-ärztlichen-psychotherapie-2 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung763137 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung7631 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung76 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung7229 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung722 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung72 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung7 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/acne-inversa-informationsveranstaltung 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-psoriasis-tag-informationsveranstaltung 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/welt-neurodermitis-tag-informationsveranstaltung 0.7 daily https://www.pchc.eu/de/neuigkeiten-events/events/informationsveranstaltung-über-menschenorientierte-versorgung-für-mitglieder-des-deutschen-psoriasis-bund-dpb